Representative Tom Price, President-elect Donald Trump's nominee to lead the Department of Health and Human Services, will appear for the first time before U.S. senators Wednesday amid growing ethics concerns and uncertainty among Republicans about how they will repeal and replace Obamacare.

In the hearing on his nomination, Price will likely face questions about his stock trades in health companies while handling health-related legislation; plans to repeal Obamacare; and Trump's recent comments about requiring pharmaceutical companies to bid for government business. Price, an orthopedic surgeon from Georgia, has opposed allowing Medicare, the U.S. health program for the elderly, to negotiate drug prices directly with manufacturers.  

Price will be a key player in the GOP's efforts to dismantle the Affordable Care Act, the outgoing president's signature law known as Obamacare. Trump said last week he wants to propose a plan to end and replace Obamacare as soon as Price is confirmed, although he gave no details about what the replacement would look like.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.